The impact of implementing an allergic rhinitis clinical management pathway (AR-CMaP) in the community pharmacy.

12 , 13 , 14 , 15 , 16 Although there is an obvious trend for people with AR to suboptimally self-select their medicines, it is evident that those with the highest burden of disease, do utilise a community pharmacy, where the pharmacist has access to AR guidelines. 17 While it is recognised that there are several challenges in optimising AR management, the suboptimal management of AR raises several questions, most importantly, how can we bridge the gap between AR guidelines for pharmacists and the optimisation of AR management for their patients?

also in 278 other papers